Ledger.Open graph →
SEC Form D · filed March 9, 2011

NEUROPHAGE PHARMACEUTICALS INC

Offering
$12.4M
Sold
$8.4M
Exemption
—
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

People & firms on this filing (11)

Hampus Hillerstrom · Cambridge, MAExecVicki Sato · Cambridge, MADirectorPaul Goldenheim · Cambridge, MADirectorValerie Calenda · Cambridge, MADirectorJonathan Solomon · Cambridge, MAExec · DirectorMichael Chandler · Goleta, CAExecJohn Bowers · Goleta, CADirectorVictoria Katsov · Goleta, CAExec · DirectorEdgar Masri · Goleta, CADirectorGeorge Schmitt · Goleta, CADirectorMark Skaletsky · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗